Scholarlink

Objective <p>To identify risk factors for opioid use and assess the effect of opioids on women with endometriosis.</p> Design <p>A retrospective cohort study.</p> Setting <p>A tertiary medical center.</p> Participants <p>Women with confirmed or suspected endometriosis aged 18–45 years.</p> Methods <p>Recruited participants completed a questionnaire including baseline demographic and general health data, a Brief Pain Inventory (BPI-Heb) and a Visual Analogue Scale assessing Endometriosis associated pain symptoms. Women using opioids were compared to women not using opioids. Women treated with opioids further completed a Visual Analogue Scale quesionniare of pain symptoms after using opioids, a questionnaire assessing side effects, and the Opioid Risk Tool for the assessment of addiction risk.</p> Results <p>Ninety-eight patients were included in the study. Of them, 49 were opioid users, and 49 were non-opioid users. One unit increase in overall pain was associated with a 28% increased risk of opioid use [OR = 1.28, 95% CI 1.1–1.5, <i>p</i> = .007]. Use of hormonal therapy and smoking also increased opioid use risk [OR = 6.16, 95% CI 1.7–22.5, <i>p</i> = 0.006, OR = 4.36, 95% CI 1.2–16.1, <i>p</i> = .027, respectively]. Within the opioid users group, all pain symptoms and quality of life domains were significantly improved, with the most significant improvement demonstrated in dysmenorrhea and sleeping quality (median change: -4.5 (<i>p</i> &lt; .001) and 5 (<i>p</i> &lt; .001) points, respectively). While there were no life-threatening side effects, 94% of women using opioids experienced at least one side effect and 33% had moderate to high risk of addiction.</p> Conclusion <p>In our study, the risk of opioid use among women with endometriosis was increased for women with hormonal therapy, smoking and higher pain severity. While opioids were associated with high rates of side effects, they were effective pain relievers and overall quality of life was improved. More research is needed to delineate better the role and risks of opioids for the treatment of endometriosis associated pain.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Opioids for management of endometriosis associated pain: balancing effectiveness and quality of life

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月6日

查看全文
  • Yael Roza Douak,
  • Nir Cohen,
  • Ilan Matok,
  • Tal Saar,
  • Uri Dior

摘要

Objective

To identify risk factors for opioid use and assess the effect of opioids on women with endometriosis.

Design

A retrospective cohort study.

Setting

A tertiary medical center.

Participants

Women with confirmed or suspected endometriosis aged 18–45 years.

Methods

Recruited participants completed a questionnaire including baseline demographic and general health data, a Brief Pain Inventory (BPI-Heb) and a Visual Analogue Scale assessing Endometriosis associated pain symptoms. Women using opioids were compared to women not using opioids. Women treated with opioids further completed a Visual Analogue Scale quesionniare of pain symptoms after using opioids, a questionnaire assessing side effects, and the Opioid Risk Tool for the assessment of addiction risk.

Results

Ninety-eight patients were included in the study. Of them, 49 were opioid users, and 49 were non-opioid users. One unit increase in overall pain was associated with a 28% increased risk of opioid use [OR = 1.28, 95% CI 1.1–1.5, p = .007]. Use of hormonal therapy and smoking also increased opioid use risk [OR = 6.16, 95% CI 1.7–22.5, p = 0.006, OR = 4.36, 95% CI 1.2–16.1, p = .027, respectively]. Within the opioid users group, all pain symptoms and quality of life domains were significantly improved, with the most significant improvement demonstrated in dysmenorrhea and sleeping quality (median change: -4.5 (p < .001) and 5 (p < .001) points, respectively). While there were no life-threatening side effects, 94% of women using opioids experienced at least one side effect and 33% had moderate to high risk of addiction.

Conclusion

In our study, the risk of opioid use among women with endometriosis was increased for women with hormonal therapy, smoking and higher pain severity. While opioids were associated with high rates of side effects, they were effective pain relievers and overall quality of life was improved. More research is needed to delineate better the role and risks of opioids for the treatment of endometriosis associated pain.